Loading, please wait...
Osteoarthritis (OA) is the most common form of arthritis; however, many people choose to self-medicate with over-the-counter (OTC) analgesics, for example, without obtaining any formal medical advice or diagnosis. Pain and disability caused by OA is well-described and often the focus of educational programming, but it is also important to consider other comorbidities that can be affected by the presence and severity of OA. Over two-thirds of patients with OA have at least one other chronic health condition (e.g., hypertension, depression, COPD, diabetes, obesity) complicating not only the treatment choices for OA, but also the suggested treatment recommendations for the comorbidities. Given the extensive impact of OA on physical function, healthcare costs, loss of income, and overall health, combined with its association with other comorbidities and the fact that disease-modifying therapies have not been identified, many of the challenges identified in OA can be opportunities for the pharmacist! The pharmacist, as the most accessible healthcare provider, is in an ideal position to screen patients for OA, serve as an educator and coach regarding prevention strategies, counsel patients on the safe and effective treatment options available, and triage when necessary.
The information conveyed in this continuing education program as well as the accompanying toolkit will give the pharmacist ideas and guidance on how to assume a more active role in the detection, prevention, and treatment of OA.
Please visit the site below for more on this program.
Fee
$0.00
CE Hours
3.00
CE Units
0.300
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
Participants have 60 days from the start of their program to claim CE credit and verify it has been upload to CPE Monitor. If your program requires the completion of a post test/eval/survey those items MUST be done before that 60 day window closes to receive credit for that program. Statements of credit can be viewed and printed from CPE Monitor. Statements of credit will no longer be printed and mailed to the participant. **No partial individual session credit will be given**
PAYMENT NOTE: During the registration process, if a fee is required, please enter the zip code associated with your credit card's BILLING ADDRESS. For security purposes payments are processed through a separate system, so when prompted, please click “ok” to be taken to that site and complete your registration. Upon successful registration of this program you will receive an email confirmation/receipt and will be returned to this program page. When you are retuned to this page you will see a note at the top of the page reading “You are registered for this program.”
If you are not automatically returned to this page or see only a blank white screen your transaction was not successful, and you will need to try again.
If paying by check please mail to the address below: 301 Pharmacy Lane, CB# 7574 Beard Hall
Chapel Hill, NC 27599
|
|
|
The University of North Carolina Eshelman School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To receive CE credit, participants must complete the CE attendance form and the online evaluation of the program (instructions to be emailed). Statements of credit can be viewed and printed in CPE Monitor approximately 2 to 3 weeks after the program and you have completed any needed requirements. **No partial credit will be available**
|
Co-Sponsor(s)
OA Action Alliance
Objectives
- Describe the prevalence of osteoarthritis and its impact on the health and quality of life.
- Explain how comorbidities impact the management of osteoarthritis and vice versa.
- Engage and counsel patients with osteoarthritis or those as risk for osteoarthritis on the proper use of nondrug and drug therapy to minimize pain and disability.
- Develop treatment strategies by using an interprofessional approach and community-based programs to minimize the burden of osteoarthritis pain.
Activity Number
0046-9999-19-089-H01-P
Release Date:
Jan 17, 2019
Credit Expiration Date:
Jan 17, 2021
CE Hours
3.00